Conference Coverage
Conference Coverage
11/07/2026
Ashton L. Stahl
In a retrospective cohort study of patients with confirmed transthyretin amyloid cardiomyopathy (ATTR-CM), AI-assisted echocardiography detected cardiac amyloidosis approximately 13 months earlier than...
11/07/2026
Conference Coverage
Conference Coverage
11/07/2026
Ashton L. Stahl
A retrospective multicenter study of 536 patients with immunoglobulin light-chain amyloid cardiomyopathy (AL-CM) found that women had lower cardiac wall thickness than men despite similar disease severity,...
11/07/2026
Conference Coverage
Conference Coverage
10/13/2026
Ashton L. Stahl
A post hoc ATTRibute-CM analysis examined cardiovascular outcomes and changes in NT-proBNP among women receiving acoramidis.
10/13/2026
Conference Coverage
Conference Coverage
10/13/2026
Brian McCurdy
A post hoc ATTRibute-CM analysis examined whether the Day 28 eGFR dip affected acoramidis outcomes through 30 months.
10/13/2026
Conference Coverage
Conference Coverage
10/13/2026
Brian McCurdy
A retrospective study compared clinical outcomes after patients with ATTR-CM started acoramidis or tafamidis.
10/13/2026
Conference Coverage
Conference Coverage
10/13/2026
Ashton L. Stahl
A post hoc ATTRibute-CM analysis examined days lost to death or cardiovascular hospitalization with acoramidis versus placebo.
10/13/2026
AHS Conference Coverage
AHS Conference Coverage
10/13/2026
Anthony Calabro, MA
A 1-year interim analysis of a phase 3, multicenter, open-label, 156-week extension study found overall reductions in systolic and diastolic blood pressure with atogepant 60 mg once daily in persons with...
10/13/2026
Conference Coverage
Conference Coverage
10/06/2026
Ashton L. Stahl
The HF Stats 2026 report examines US heart failure trends, highlighting rising mortality, younger patients, and gaps in treatment.
10/06/2026
Conference Coverage
Conference Coverage
10/06/2026
Ashton L. Stahl
HFSA 2026 will spotlight late-breaking trials in heart failure drugs, amyloidosis imaging, cardiomyopathy, and device-based care.
10/06/2026
Research Summary
Research Summary
10/05/2026
Ashton L. Stahl
Study compares the American Heart Association/American College of Cardiology/multisociety 2026 and 2018 lipid guidelines to assess changes in US eligibility for primary prevention statin therapy.
10/05/2026